Concepedia

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

Ιrene Karampela, Μaria Dalamaga

Archives of Medical Research · 2020 · 130 citations · 10 references

DOIFull text

Open access

Concepts

References

10

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

, , +15

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

Joshua P. Metlay, Grant Waterer, Ann C. Long et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 3.6K citations · Full text

, , +17

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Mandeep R. Mehra, Sapan S. Desai, Frank Ruschitzka et al. · The Lancet · 2020 · 1.3K citations · Full text

, , +9

Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus–Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Ashley Miller, Ashley E. Glode, Kathy R. Hogan et al. · Biology of Blood and Marrow Transplantation · 2010 · 83 citations · Full text

, , +16

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Krzysztof Marciniec, Artur Beberok, Paweł Pęcak et al. · Pharmacological Reports · 2020 · 79 citations · Full text

, , +17